Searchable abstracts of presentations at key conferences in endocrinology

ea0063p80 | Calcium and Bone 1 | ECE2019

Effects of bariatric surgery on bone health

Exposito Maria Rosa Alhambra , Martin Ana Barrera , Jimenez Concepcion Munoz , Puerta Maria Jose Molina , Moreno Maria Angeles Galvez

Introduction: Bariatric surgery has important metabolic complications such as bone mass loss.Goal: To assess bone mineral density (BMD) after Roux-en-Y gastric by-pass (RYGB) in patients under standard calcium and vitamin D supplementation.Method: In patients with morbid obesity submitted to RYGB, we measured BMD with a dual X-ray densitometer. Using World Health Organization (WHO) criteria’s, values were compared with young c...

ea0063p793 | Thyroid 2 | ECE2019

Follicular lesion of undetermined thyroid significance: therapeutic approach to the diagnosis of bethesda 3

Martin Ana Barrera , Exposito Maria Rosa Alhambra , Roman Angel Rebollo , Azpilcueta Pedro Segui , Moreno Maria Angeles Galvez

Introduction: Thyroid nodules are very common in the general population (20–75% ultrasound). There are clinical management criteria established by international societies and standardized cytological diagnostic criteria (Bethesda). However, there is still uncertainty in the management of category 3 (follicular lesion of undetermined significance). Objectives: To evaluate the clinical attitude to the cytological diagnosis of Bethesda category 3 (B3) in thyroid fine-needle ...

ea0056p487 | Diabetes therapy | ECE2018

Second setp in type 2 diabetes, what to choose?

Exposito Maria Rosa Alhambra , Moreno Paloma Moreno , Martin Ana Barrera , Sanchez Inmaculada Prior , Moreno Maria Angeles Galvez

Introduction: In type 2 diabetes the choice of the second drug after metformina is marked by the basic characteristics of the patient.Objetive: To analyze in real clinical practice the effectiveness of different antidiabetics.Material and methods: Observational study including patients with type 2 diabetes, in which we added to metformina different antidiabetics. We revised them 3-6 months from change.Results...

ea0063gp34 | Diabetes and Cardiovascular Disease | ECE2019

Stroke in diabetic patients and cardiovascular risk factors control

Idougourram Soraya Leon , Martin Ana Barrera , Roman Angel Rebollo , Moreno Paloma Moreno , Laguna Maria Alcantara , Ortega Rafael Palomares , Moreno Maria Angeles Galvez

Introduction: Strokes are common diabetes macrovascular complications. A good control of cardiovascular risk factors such as glycemic control has been proven to reduce the risk of its appearance. Aim: Describe diabetes prevalence in patients admitted to hospital because of a stroke, as well as their treatment and metabolic control.Patients and methods: Observational retrospective study of patients admitted to the Neurology section because of a s...

ea0056p374 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Insulin resistance and β-cell function in patients with cystic fibrosis

Roman Angel Rebollo , Moreno Paloma Moreno , Martin Ana Barrera , Exposito Maria Rosa Alhambra , Laguna Maria Dolores Alcantara , Barrios Jose Manuel Vaquero , Continente Alfonso Calanas , Moreno Maria Angeles Galvez

Introduction: Recent studies defend the measurements of insulin resistance and β-cell function to assess the endocrine pancreatic function in patients with cystic fibrosis (CF). HOMA-IR indexes greater than 1 translate insulin resistance and HOMA-%β values lower than 100% imply an altered β-cell function.Aim: To describe insulin resistance and β-cell function using HOMA-IR and HOMA-%β indexes in patients with CF and compare them ...

ea0056p1070 | Thyroid (non-cancer) | ECE2018

Final diagnosis of thyroid nodules classified as Bethesda-4 after Fine-needle aspiration

Martin Ana Barrera , Alcantara Laguna Maria , Roman Angel Rebollo , Exposito Maria Rosa Alhambra , Moreno Paloma Moreno , Azpilcueta Pedro Segui , Moreno Maria Angeles Galvez

Introduction: Fine-needle aspiration (FNA) is indicated in suspicious thyroid nodules or big ones. Bethesda system classifies them according to the cytological malignancy risk. Bethesda category 4 (B4) comprises follicular neoplasms and suspicious follicular neoplasms. Aim: Determine final diagnosis of B4 nodules and study associations between malignancy and other variables.Methods: Retrospective study of patients with nodules classified as B4 a...